Daniel Allar

""



Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

LATEST ARTICLES BY THIS AUTHOR

Companies back paclitaxel-coated devices after unfavorable study
Pea-sized PDA occluder approved for premature babies in US
Study: Continued anticoagulation OK during TAVR for AFib patients
FDA fast-tracks review process for cardiac amyloidosis drug
Long-term survival encouraging after surgical correction of PCI-related complications
Study: 4% of childhood cancer survivors develop heart failure within 40 years
Guideline-recommended statin treatment ‘hampered’ by clinician beliefs
Psychosocial evaluation predicts readmission risk for LVAD patients
Surgical strategies, genetics affect tetralogy of Fallot survival
Women with HFrEF live longer but suffer more